[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BR112014026088A2 - produto de tratamento de tecidos, estojo, método de fabricação de um produto de tratamento de tecidos, método de tratamento, e uso do produto de tratamento de tecidos - Google Patents

produto de tratamento de tecidos, estojo, método de fabricação de um produto de tratamento de tecidos, método de tratamento, e uso do produto de tratamento de tecidos

Info

Publication number
BR112014026088A2
BR112014026088A2 BR112014026088A BR112014026088A BR112014026088A2 BR 112014026088 A2 BR112014026088 A2 BR 112014026088A2 BR 112014026088 A BR112014026088 A BR 112014026088A BR 112014026088 A BR112014026088 A BR 112014026088A BR 112014026088 A2 BR112014026088 A2 BR 112014026088A2
Authority
BR
Brazil
Prior art keywords
tissue
treatment product
tissue treatment
manufacturing
care products
Prior art date
Application number
BR112014026088A
Other languages
English (en)
Other versions
BR112014026088B1 (pt
Inventor
Owens Rick
Liu Zhigang
Original Assignee
Lifecell Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lifecell Corp filed Critical Lifecell Corp
Publication of BR112014026088A2 publication Critical patent/BR112014026088A2/pt
Publication of BR112014026088B1 publication Critical patent/BR112014026088B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/50—Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/362—Skin, e.g. dermal papillae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Materials For Medical Uses (AREA)

Abstract

resumo produto de tratamento de tecidos, estojo, método de fabricação de um produto de tratamento de tecidos, método de tratamento, e uso do produto de tratamento de tecidos são revelados aqui produtos de tratamento de tecidos que foram ligados a pelo menos um agente quelante. também são revelados produtos de tratamento de tecidos que foram funcionalizados com pelo menos um metal e/ou pelo menos uma proteína ligante de metal. os produtos de tratamento de tecidos podem ter propriedades antimicrobianas e/ou fatores que promovem ou intensificam a migração, proliferação, e/ou revascularização de células nativas após implantação em um sujeito. também são revelados métodos de fabricação e uso dos produtos de tratamento de tecidos. os produtos de tratamento de tecidos podem ser implantados em um tecido necessitado de reparação, regeneração, cura, tratamento, e/ou alteração e podem promover ou intensificar a migração, proliferação, e/ou revascularização de células nativas. 1/1
BR112014026088-5A 2012-04-24 2013-04-18 produto de tratamento de tecidos BR112014026088B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261637413P 2012-04-24 2012-04-24
PCT/US2013/037133 WO2013162997A1 (en) 2012-04-24 2013-04-18 Functionalized tissue matrices

Publications (2)

Publication Number Publication Date
BR112014026088A2 true BR112014026088A2 (pt) 2017-07-18
BR112014026088B1 BR112014026088B1 (pt) 2019-11-05

Family

ID=48225134

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014026088-5A BR112014026088B1 (pt) 2012-04-24 2013-04-18 produto de tratamento de tecidos

Country Status (7)

Country Link
US (2) US9999637B2 (pt)
EP (2) EP3566727B1 (pt)
AU (1) AU2013252673C1 (pt)
BR (1) BR112014026088B1 (pt)
CA (1) CA2871635A1 (pt)
ES (1) ES2749178T3 (pt)
WO (1) WO2013162997A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013162997A1 (en) 2012-04-24 2013-10-31 Lifecell Corporation Functionalized tissue matrices
US9238090B1 (en) 2014-12-24 2016-01-19 Fettech, Llc Tissue-based compositions
JP2018534353A (ja) * 2015-10-02 2018-11-22 ディルッチオ，ロベルト 感染の防御を提供する軟組織増大のための組成物
US11224678B2 (en) * 2016-02-09 2022-01-18 Rutgers, The State University Of New Jersey Antimicrobial composition for inhibiting microbial organisms in allograft and the method thereof
US10945831B2 (en) 2016-06-03 2021-03-16 Musculoskeletal Transplant Foundation Asymmetric tissue graft
USD856517S1 (en) 2016-06-03 2019-08-13 Musculoskeletal Transplant Foundation Asymmetric tissue graft
CA3075099A1 (en) 2017-10-18 2019-04-25 Lifecell Corporation Adipose tissue products and methods of production
US11123375B2 (en) 2017-10-18 2021-09-21 Lifecell Corporation Methods of treating tissue voids following removal of implantable infusion ports using adipose tissue products
US11826488B2 (en) * 2017-10-19 2023-11-28 Lifecell Corporation Flowable acellular tissue matrix products and methods of production
US11246994B2 (en) * 2017-10-19 2022-02-15 Lifecell Corporation Methods for introduction of flowable acellular tissue matrix products into a hand
US10813743B2 (en) 2018-09-07 2020-10-27 Musculoskeletal Transplant Foundation Soft tissue repair grafts and processes for preparing and using same
USD895812S1 (en) 2018-09-07 2020-09-08 Musculoskeletal Transplant Foundation Soft tissue repair graft
BR112021024043A2 (pt) 2019-05-30 2022-02-08 Lifecell Corp Implante mamário biológico

Family Cites Families (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3323352A (en) 1965-01-04 1967-06-06 Branson Instr Control circuit for resonant sensing device
US3333803A (en) 1966-02-16 1967-08-01 Robert D Landis Eaves trough support
US4352883A (en) 1979-03-28 1982-10-05 Damon Corporation Encapsulation of biological material
US4347841A (en) 1981-03-11 1982-09-07 Human Oltoanyagtermelo Es Kutato Intezet Biological wound covering and method for producing same
US4350629A (en) 1981-07-29 1982-09-21 Massachusetts Institute Of Technology Procedures for preparing composite materials from collagen and glycosaminoglycan
US4776173A (en) 1985-12-20 1988-10-11 Angio-Medical Corporation Method for extracting a substance from animal derived material
DE3619197A1 (de) 1986-06-07 1987-12-10 Ethicon Gmbh Polsterartiges implantat
US4854316A (en) 1986-10-03 1989-08-08 Davis Emsley A Apparatus and method for repairing and preventing para-stomal hernias
US5290558A (en) 1989-09-21 1994-03-01 Osteotech, Inc. Flowable demineralized bone powder composition and its use in bone repair
US5648330A (en) 1990-04-06 1997-07-15 La Jolla Cancer Research Foundation Method and composition for treating vascular graft occlusion
AU650045B2 (en) 1990-09-12 1994-06-09 Lifecell Corporation Method and apparatus for cryopreparation dry stabilization and rehydration of biological suspensions
US5256140A (en) 1992-03-27 1993-10-26 Fallien Cosmeceuticals, Ltd. Composition for levelling skin
US5942496A (en) 1994-02-18 1999-08-24 The Regent Of The University Of Michigan Methods and compositions for multiple gene transfer into bone cells
US6174320B1 (en) 1994-09-29 2001-01-16 Bard Asdi Inc. Hernia mesh patch with slit
US5634931A (en) 1994-09-29 1997-06-03 Surgical Sense, Inc. Hernia mesh patches and methods of their use
US5695998A (en) 1995-02-10 1997-12-09 Purdue Research Foundation Submucosa as a growth substrate for islet cells
US6231608B1 (en) 1995-06-07 2001-05-15 Crosscart, Inc. Aldehyde and glycosidase-treated soft and bone tissue xenografts
US6166288A (en) 1995-09-27 2000-12-26 Nextran Inc. Method of producing transgenic animals for xenotransplantation expressing both an enzyme masking or reducing the level of the gal epitope and a complement inhibitor
US6833408B2 (en) 1995-12-18 2004-12-21 Cohesion Technologies, Inc. Methods for tissue repair using adhesive materials
EP0888142B1 (en) * 1996-03-04 2003-05-28 Edwards Lifesciences Corporation Nonpolymeric epoxy compounds for cross-linking biological tissue and bioprosthetic grafts prepared thereby
US5712252A (en) 1996-03-08 1998-01-27 The University Of Tennessee Research Corporation Method of augmenting soft tissue in mammals
US20030157187A1 (en) 1996-12-02 2003-08-21 Angiotech Pharmaceuticals, Inc. Compositions and methods for treating or preventing inflammatory diseases
US6197036B1 (en) 1997-10-01 2001-03-06 Scimed Life Systems, Inc. Pelvic floor reconstruction
US5972007A (en) 1997-10-31 1999-10-26 Ethicon Endo-Surgery, Inc. Energy-base method applied to prosthetics for repairing tissue defects
US7019192B2 (en) 1998-02-27 2006-03-28 Musculoskeletal Transplant Foundation Composition for filling bone defects
US20030039678A1 (en) 1998-03-16 2003-02-27 Stone Kevin R. Xenograft bone matrix for orthopedic applications
US6933326B1 (en) 1998-06-19 2005-08-23 Lifecell Coporation Particulate acellular tissue matrix
DK1100417T3 (da) 1998-08-03 2004-08-02 Synthes Ag Intervertebralt allograftafstandsstykke
WO2000007639A1 (en) 1998-08-07 2000-02-17 Tissue Engineering, Inc. Bone precursor compositions
WO2000016822A1 (en) 1998-09-21 2000-03-30 The Brigham And Women's Hospital, Inc. Compositions and methods for tissue repair
WO2000047114A1 (en) 1999-02-12 2000-08-17 Collagenesis, Inc. Injectable collagen-based delivery system for bone morphogenic proteins
US6381026B1 (en) 1999-03-15 2002-04-30 Lifecell Corp. Method of measuring the contour of a biological surface
US6132986A (en) 1999-04-23 2000-10-17 Sulzer Carbomedics Inc. Tissue crosslinking for bioprostheses using activated difunctional or polyfunctional acids
EP1060714B1 (en) 1999-06-08 2006-08-02 Ethicon, Inc. Knitted surgical mesh
AU5807400A (en) 1999-07-15 2001-02-19 Biotap A/S Implant
US6599318B1 (en) 1999-11-30 2003-07-29 Shlomo Gabbay Implantable support apparatus and method of using same
US20070009586A1 (en) 2000-02-29 2007-01-11 Cohen Kelman I Wound dressings containing complexes of transition metals and alginate for elastase sequestering
AR027685A1 (es) 2000-03-22 2003-04-09 Synthes Ag Forma de tejido y metodo para realizarlo
US9387094B2 (en) 2000-07-19 2016-07-12 Warsaw Orthopedic, Inc. Osteoimplant and method of making same
US6610006B1 (en) 2000-07-25 2003-08-26 C. R. Bard, Inc. Implantable prosthesis
US6432436B1 (en) 2000-10-03 2002-08-13 Musculoskeletal Transplant Foundation Partially demineralized cortical bone constructs
GB0024903D0 (en) 2000-10-11 2000-11-22 Ellis Dev Ltd A textile prothesis
US20020082697A1 (en) 2000-12-22 2002-06-27 Damien Christopher J. Implantable osteogenic material
US6776800B2 (en) 2001-02-28 2004-08-17 Synthes (U.S.A.) Implants formed with demineralized bone
US7153518B2 (en) 2001-08-27 2006-12-26 Regeneration Technologies, Inc. Processed soft tissue for topical or internal application
JP4451658B2 (ja) 2001-10-18 2010-04-14 ライフセル コーポレーション 組織および器官のリモデリング
US6790213B2 (en) 2002-01-07 2004-09-14 C.R. Bard, Inc. Implantable prosthesis
US7744597B2 (en) 2002-06-26 2010-06-29 Lifenet Health Device and process for producing fiber products and fiber products produced thereby
DK174649B1 (da) 2002-07-25 2003-08-04 Nortec Holding S A Implantat
AU2003270028A1 (en) 2002-08-23 2004-03-11 Proxy Biomedical Limited Three dimensional implant
US7824701B2 (en) 2002-10-18 2010-11-02 Ethicon, Inc. Biocompatible scaffold for ligament or tendon repair
WO2004053112A1 (en) 2002-12-12 2004-06-24 Osteotech, Inc. Formable and settable polymer bone composite and method of production thereof
EP1592361A2 (en) 2003-02-11 2005-11-09 C.R. Bard, Inc. Implantable hernia repair system
US20100221237A1 (en) * 2003-03-26 2010-09-02 Biosynexus Incorporated Enzyme disruption of bacterial biofilms
ATE455563T1 (de) 2003-04-04 2010-02-15 Tissuemed Ltd Zusammensetzungen für die gewebeadhäsion
US7105001B2 (en) 2003-05-21 2006-09-12 Mandelbaum Jon A Surgical method and composition utilizing submucosal tissue to prevent incisional hernias
US7338517B2 (en) 2003-06-04 2008-03-04 University Of South Carolina Tissue scaffold having aligned fibrils and artificial tissue comprising the same
EP1628693A1 (en) 2003-06-04 2006-03-01 Inion Ltd. Biodegradable implant and method for manufacturing one
US7413734B2 (en) 2003-06-27 2008-08-19 Ethicon, Incorporated Treatment of retinitis pigmentosa with human umbilical cord cells
CA2533259C (en) 2003-07-21 2014-01-28 Lifecell Corporation Acellular tissue matrices made from galactose .alpha.-1,3-galactose-deficient tissue
WO2005025630A1 (en) 2003-09-10 2005-03-24 Cato T Laurencin Polymeric nanofibers for tissue engineering and drug delivery
US7815561B2 (en) 2003-09-25 2010-10-19 Xoft, Inc. Brachytherapy applicator
WO2005042048A2 (en) 2003-10-22 2005-05-12 Encelle, Inc. Bioactive hydrogel compositions for regenerating connective tissue
US20050113849A1 (en) 2003-11-26 2005-05-26 Nicholas Popadiuk Prosthetic repair device
DE102004020469A1 (de) 2004-04-26 2005-11-10 Gfe Medizintechnik Gmbh Flächiges Netzimplantat zur Hernienversorgung
US20050288691A1 (en) 2004-06-28 2005-12-29 Leiboff Arnold R Hernia patch
US20080091277A1 (en) 2004-08-13 2008-04-17 Kai Deusch Surgical prosthesis having biodegradable and nonbiodegradable regions
EP1827480B1 (en) 2004-12-21 2016-11-09 MUSC Foundation For Research Development Compositions and methods for promoting wound healing and tissue regeneration
EP1865970A4 (en) 2005-03-23 2010-11-10 Childrens Medical Center METHOD OF CLINICAL TREATMENT WITH MINIMAL EFFRACTION FOR CLOSING UMBILICAL HERNIES
US20070111937A1 (en) 2005-03-24 2007-05-17 Pickar James H Use of fibrous tissue inducing proteins for hernia repair
JP5002805B2 (ja) 2005-10-14 2012-08-15 財団法人ヒューマンサイエンス振興財団 生物由来スキャフォールドの作製方法
US8252333B2 (en) 2006-01-26 2012-08-28 Jorge Cueto-Garcia Biodegradable, non-toxic biological adhesive for use in abdominal surgery
GB0606231D0 (en) 2006-03-29 2006-05-10 Univ Leeds Improvements relating to decellurisation of tissue matrices for bladder implantation
CN101553189A (zh) 2006-05-09 2009-10-07 生命细胞公司 加强的生物组织
US20070293878A1 (en) 2006-06-16 2007-12-20 Butsch John L Magnetic mesh support for tissue walls
US8192760B2 (en) 2006-12-04 2012-06-05 Abbott Cardiovascular Systems Inc. Methods and compositions for treating tissue using silk proteins
GB2457853B (en) 2007-01-10 2012-02-29 Cook Biotech Inc Implantable devices useful for reinforcing a surgically created stoma
EP2162142B1 (en) 2007-07-10 2015-12-02 Lifecell Corporation Acellular tissue matrix compositions for tissue repair
WO2009114520A2 (en) * 2008-03-10 2009-09-17 Pharmain Corporation Compositions for treatment with metallopeptidases, methods of making and using the same
EP3744357A1 (en) 2008-08-14 2020-12-02 3M Innovative Properties Company Tissue scaffolds
CN102215788A (zh) 2008-11-20 2011-10-12 生命细胞公司 用于治疗和预防造口旁疝的方法
US8333803B2 (en) 2008-11-21 2012-12-18 Lifecell Corporation Reinforced biologic material
RU2011122546A (ru) 2008-12-31 2013-02-10 КейСиАй ЛАЙСЕНЗИНГ, ИНК. Системы для обеспечения ткани потоком текучей среды
US20110135703A1 (en) * 2009-12-08 2011-06-09 Shipp John I Antimicrobial Coating for Surgical Implants and Method of Use
EP2696908B1 (en) 2011-04-14 2015-03-11 Lifecell Corporation Regenerative materials
EP3851131A1 (en) 2011-05-31 2021-07-21 LifeCell Corporation Adipose tissue matrices
WO2013162997A1 (en) 2012-04-24 2013-10-31 Lifecell Corporation Functionalized tissue matrices

Also Published As

Publication number Publication date
US20180264037A1 (en) 2018-09-20
WO2013162997A1 (en) 2013-10-31
US9999637B2 (en) 2018-06-19
CA2871635A1 (en) 2013-10-31
US20130280223A1 (en) 2013-10-24
AU2013252673C1 (en) 2017-01-19
EP3566727A1 (en) 2019-11-13
ES2749178T3 (es) 2020-03-19
EP2841115A1 (en) 2015-03-04
AU2013252673B2 (en) 2016-07-28
BR112014026088B1 (pt) 2019-11-05
AU2013252673A1 (en) 2014-10-30
EP2841115B1 (en) 2019-07-10
US10953044B2 (en) 2021-03-23
EP3566727B1 (en) 2021-12-08

Similar Documents

Publication Publication Date Title
BR112014026088A2 (pt) produto de tratamento de tecidos, estojo, método de fabricação de um produto de tratamento de tecidos, método de tratamento, e uso do produto de tratamento de tecidos
BR112014026090A2 (pt) composição de matriz tecidual apta a fluir, estojo, método de fabricação de uma composição de matriz tecidual apta a fluir, método de tratamento, e uso da composição de matriz tecidual apta a fluir
BR112018067379A2 (pt) conjugado anticorpo-droga, composição, método para tratamento de um paciente que tem ou corre o risco de ter um câncer, para produzir o conjugado anticorpo-droga ou a composição, para determinar se um paciente será responsivo a um tratamento com o conjugado anticorpo-droga ou a composição, e, uso de um conjugado anticorpo-droga ou de uma composição.
PH12018500810A1 (en) Antibody agents specific for human cd19 and uses thereof
BR112015023212A2 (pt) tratamento do câncer utilizando anticorpos que se ligam à grp78 da superfície celular
CY1121097T1 (el) Ανθρωπινα αντισωματα κατα toy gfr 3 και μεθοδοι χρησης αυτων
BR112022008744A2 (pt) Ligante de il-2rss, ligante de il-2r¿c, composto de ligação a il-2r¿¿c, composição farmacêutica, método para tratar uma doença em um paciente, método para expandir células imunes, método de uma terapia celular, método para reforçar uma vacina, método para modificar a resposta imune e ácido nucleico
BR112014018728A8 (pt) Compostos de purinonas como inibidores de quinase
BR112016006978A2 (pt) inibidores de tirosina quinase de bruton
MX2018001532A (es) Anticuerpos anti-angptl8 y usos de estos.
BR112017014332A2 (pt) métodos de tratamento de doenças retinianas
BR112014018047A8 (pt) Composição de tratamento de tecido
BR112018013407A2 (pt) anticorpos e conjugados dos mesmos
BR112022019020A2 (pt) Proteínas de fusão de il12 mascaradas e métodos de uso das mesmas
BRPI0622054B8 (pt) composto e composição farmacêutica
BR112017008726A2 (pt) usos de um extrato de fermento e de um exopolissacarídeo, e, composição cosmética.
BR112017004349A2 (pt) terapia com gene de globina para o tratamento de hemoglobinopatias
BR112016004095A2 (pt) administração de enzimas de empobrecimento de quinurenina para a terapia contra tumores
BR112015028278A2 (pt) processo para a preparação de eritrócitos carregados com uma ou mais substâncias de interesse farmacêutico e eritrócitos assim obtidos
BR112015026247A2 (pt) métodos para o tratamento de câncer com o uso de terapia combinada com inibidor de cinase tor
PH12019501945A1 (en) Composition and method for preventing or delaying onset of myopia comprising atropine
BR112017017218A2 (pt) ?processo para o tratamento das fibras de queratina, composição, utilização de um ou mais polissacarídeos e conjunto ou dispositivo de compartimentos múltiplos?
EA201591581A1 (ru) Способы лечения псориаза при помощи анти-il-23 антитела
EA202092748A1 (ru) Модуляторы экспрессии apol1
BR112022018645A2 (pt) Composições e métodos para tratar ou prevenir doenças inflamatórias, incluindo diabetes mellitus tipo i e tipo ii e doenças da tireoide

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 18/04/2013, OBSERVADAS AS CONDICOES LEGAIS.